Advertisement

Index by author

March 01, 2001; Volume 29,Issue 3

A

  1. Alexander, Rakki P.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

B

  1. Back, David J.

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  2. Blouin, Robert A.

    1. Tissue-Specific Alterations in the 6-Hydroxylation of Chlorzoxazone Following Traumatic Brain Injury in the Rat
      Samuel M. Poloyac, Alex Perez, Stephen Scheff and Robert A. Blouin
      Drug Metabolism and Disposition March 2001, 29 (3) 296-298;

  3. Buhler, Donald R.

    1. In Vitro Biotransformation of Xanthohumol, a Flavonoid from Hops (Humulus lupulus), by Rat Liver Microsomes
      Meltem Yilmazer, Jan F. Stevens, Max L. Deinzer and Donald R. Buhler
      Drug Metabolism and Disposition March 2001, 29 (3) 223-231;

C

  1. Carrère, Nicolas

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  2. Cassidy, Kenneth C.

    1. Characterization of 2-[[4-[[2-(1H-Tetrazol-5-ylmethyl)phenyl]methoxy]phenoxy]methyl] Quinoline N-Glucuronidation by in Vitro and in Vivo Approaches
      Jeffrey C. Stevens, Jessica L. Fayer and Kenneth C. Cassidy
      Drug Metabolism and Disposition March 2001, 29 (3) 289-295;

  3. Chandy, Mammen

    1. Glutathione S-Transferase Activity Influences Busulfan Pharmacokinetics in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation
      Balasubramanian Poonkuzhali, Mammen Chandy, Alok Srivastava, David Dennison and Rajagopal Krishnamoorthy
      Drug Metabolism and Disposition March 2001, 29 (3) 264-267;

  4. Chauret, Nathalie

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  5. Cheng, Ching-Ling

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  6. Chiba, Masato

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  7. Chmela, Zdeněk

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

  8. Chung, Hye Chin

    1. Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
      Hye Chin Chung, Sang Hyun Sung, Jin Soo Kim, Young Choong Kim and Sang Geon Kim
      Drug Metabolism and Disposition March 2001, 29 (3) 213-216;

D

  1. Daujat, Martine

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  2. DeFeo-Jones, Deborah

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  3. Deinzer, Max L.

    1. In Vitro Biotransformation of Xanthohumol, a Flavonoid from Hops (Humulus lupulus), by Rat Liver Microsomes
      Meltem Yilmazer, Jan F. Stevens, Max L. Deinzer and Donald R. Buhler
      Drug Metabolism and Disposition March 2001, 29 (3) 223-231;

  4. Dennison, David

    1. Glutathione S-Transferase Activity Influences Busulfan Pharmacokinetics in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation
      Balasubramanian Poonkuzhali, Mammen Chandy, Alok Srivastava, David Dennison and Rajagopal Krishnamoorthy
      Drug Metabolism and Disposition March 2001, 29 (3) 264-267;

  5. Dewey, Michael J.

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  6. Dunbar, Deborah

    1. Metabolic Characterization of the Major Human Small Intestinal Cytochrome P450s
      R. Scott Obach, Qing-Yu Zhang, Deborah Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2001, 29 (3) 347-352;

E

  1. Edwards, Robert J.

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

  2. Ellis, Joan D.

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

F

  1. Fabre, Jean-Michel

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  2. Fayer, Jessica L.

    1. Characterization of 2-[[4-[[2-(1H-Tetrazol-5-ylmethyl)phenyl]methoxy]phenoxy]methyl] Quinoline N-Glucuronidation by in Vitro and in Vivo Approaches
      Jeffrey C. Stevens, Jessica L. Fayer and Kenneth C. Cassidy
      Drug Metabolism and Disposition March 2001, 29 (3) 289-295;

  3. Feng, Dong-Mei

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  4. Forkert, Poh-Gek

    1. Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes
      Poh-Gek Forkert, Raymond P. Lee and Ken Reid
      Drug Metabolism and Disposition March 2001, 29 (3) 258-263;

  5. Fuksová, Květoslava

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

G

  1. Garsky, Victor M.

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  2. Gerbal-Chaloin, Sabine

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  3. Guengerich, F. Peter

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

H

  1. Halberg, Daniel L.

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  2. Halifax, Kathryn

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  3. Hanuš, Jan

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

  4. Havlı́ček, Libor

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

  5. Hite, Karen M.

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  6. Holladay, John W.

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  7. Hollenberg, Paul F.

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

  8. Honda, Tomoyo

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  9. Honma, Wataru

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  10. Hsieh, Kun-Pin

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  11. Huang, Jin-Ding

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  12. Huang, Wei

    1. Variables in Human Liver Microsome Preparation: Impact on the Kinetics of L-α-Acetylmethadol (LAAM)N-Demethylation and DextromethorphanO-Demethylation
      Ann C. Nelson, Wei Huang and David E. Moody
      Drug Metabolism and Disposition March 2001, 29 (3) 319-325;

I

  1. Ikeda, Toshihiko

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  2. Ishigami, Michi

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  3. Ito, Kiyomi

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

J

  1. Jones, Raymond E.

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  2. Juvonen, Risto

    1. In Vitro Inhibition of Cytochrome P450 Enzymes in Human Liver Microsomes by a Potent CYP2A6 inhibitor, trans-2-Phenylcyclopropylamine (Tranylcypromine), and Its Nonamine Analog, Cyclopropylbenzene
      Päivi Taavitsainen, Risto Juvonen and Olavi Pelkonen
      Drug Metabolism and Disposition March 2001, 29 (3) 217-222;

K

  1. Kaminsky, Laurence S.

    1. Metabolic Characterization of the Major Human Small Intestinal Cytochrome P450s
      R. Scott Obach, Qing-Yu Zhang, Deborah Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2001, 29 (3) 347-352;

  2. Kamiyama, Yoshiteru

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  3. Kim, Hyesook

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

  4. Kim, Jin Soo

    1. Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
      Hye Chin Chung, Sang Hyun Sung, Jin Soo Kim, Young Choong Kim and Sang Geon Kim
      Drug Metabolism and Disposition March 2001, 29 (3) 213-216;

  5. Kim, Sang Geon

    1. Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
      Hye Chin Chung, Sang Hyun Sung, Jin Soo Kim, Young Choong Kim and Sang Geon Kim
      Drug Metabolism and Disposition March 2001, 29 (3) 213-216;

  6. Kim, Young Choong

    1. Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
      Hye Chin Chung, Sang Hyun Sung, Jin Soo Kim, Young Choong Kim and Sang Geon Kim
      Drug Metabolism and Disposition March 2001, 29 (3) 213-216;

  7. Komai, Toru

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  8. Krishnamoorthy, Rajagopal

    1. Glutathione S-Transferase Activity Influences Busulfan Pharmacokinetics in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation
      Balasubramanian Poonkuzhali, Mammen Chandy, Alok Srivastava, David Dennison and Rajagopal Krishnamoorthy
      Drug Metabolism and Disposition March 2001, 29 (3) 264-267;

  9. Kryštof, Vladimı́r

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

L

  1. Lai, Ming-Liang

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  2. Lee, Raymond P.

    1. Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes
      Poh-Gek Forkert, Raymond P. Lee and Ken Reid
      Drug Metabolism and Disposition March 2001, 29 (3) 258-263;

  3. Lemr, Karel

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

  4. Li, Chun

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  5. Li-Masters, Tong

    1. Effects of Bacterial Lipopolysaccharide on Phenobarbital-Induced CYP2B Expression in Mice
      Tong Li-Masters and Edward T. Morgan
      Drug Metabolism and Disposition March 2001, 29 (3) 252-257;

  6. Liang, Zhenmin

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  7. Lin, Jiunn H.

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

  8. Lin, Min-Shung

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  9. Lin, Yen-Yu

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  10. Lindup, W. Edward

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  11. Lukeš, Jiřı́

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

M

  1. MacDonald, Dwight

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  2. Matias, Jocelyn

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  3. Maurel, Patrick

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  4. Michniak, Bozena B.

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  5. Michnová, Lucie

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

  6. Monks, Anne

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  7. Moody, David E.

    1. Variables in Human Liver Microsome Preparation: Impact on the Kinetics of L-α-Acetylmethadol (LAAM)N-Demethylation and DextromethorphanO-Demethylation
      Ann C. Nelson, Wei Huang and David E. Moody
      Drug Metabolism and Disposition March 2001, 29 (3) 319-325;

  8. Morgan, Edward T.

    1. Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How?
      Edward T. Morgan
      Drug Metabolism and Disposition March 2001, 29 (3) 207-212;
    2. Effects of Bacterial Lipopolysaccharide on Phenobarbital-Induced CYP2B Expression in Mice
      Tong Li-Masters and Edward T. Morgan
      Drug Metabolism and Disposition March 2001, 29 (3) 252-257;

N

  1. Nagata, Kiyoshi

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  2. Nelson, Ann C.

    1. Variables in Human Liver Microsome Preparation: Impact on the Kinetics of L-α-Acetylmethadol (LAAM)N-Demethylation and DextromethorphanO-Demethylation
      Ann C. Nelson, Wei Huang and David E. Moody
      Drug Metabolism and Disposition March 2001, 29 (3) 319-325;

  3. Nicoll-Griffith, Deborah A.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  4. Novak, Raymond F.

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

O

  1. Obach, R. Scott

    1. Metabolic Characterization of the Major Human Small Intestinal Cytochrome P450s
      R. Scott Obach, Qing-Yu Zhang, Deborah Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2001, 29 (3) 347-352;

  2. Oliff, Allen

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

P

  1. Pang, K. Sandy

    1. Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes
      Eugene Tan and K. Sandy Pang
      Drug Metabolism and Disposition March 2001, 29 (3) 335-346;

  2. Parton, Ted

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  3. Pascussi, Jean-Marc

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  4. Pelkonen, Olavi

    1. In Vitro Inhibition of Cytochrome P450 Enzymes in Human Liver Microsomes by a Potent CYP2A6 inhibitor, trans-2-Phenylcyclopropylamine (Tranylcypromine), and Its Nonamine Analog, Cyclopropylbenzene
      Päivi Taavitsainen, Risto Juvonen and Olavi Pelkonen
      Drug Metabolism and Disposition March 2001, 29 (3) 217-222;

  5. Perez, Alex

    1. Tissue-Specific Alterations in the 6-Hydroxylation of Chlorzoxazone Following Traumatic Brain Injury in the Rat
      Samuel M. Poloyac, Alex Perez, Stephen Scheff and Robert A. Blouin
      Drug Metabolism and Disposition March 2001, 29 (3) 296-298;

  6. Perrier, Helene

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  7. Pichard-Garcia, Lydiane

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  8. Poloyac, Samuel M.

    1. Tissue-Specific Alterations in the 6-Hydroxylation of Chlorzoxazone Following Traumatic Brain Injury in the Rat
      Samuel M. Poloyac, Alex Perez, Stephen Scheff and Robert A. Blouin
      Drug Metabolism and Disposition March 2001, 29 (3) 296-298;

  9. Poonkuzhali, Balasubramanian

    1. Glutathione S-Transferase Activity Influences Busulfan Pharmacokinetics in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation
      Balasubramanian Poonkuzhali, Mammen Chandy, Alok Srivastava, David Dennison and Rajagopal Krishnamoorthy
      Drug Metabolism and Disposition March 2001, 29 (3) 264-267;

  10. Putt, David A.

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

R

  1. Reid, Ken

    1. Involvement of CYP2E1 and Carboxylesterase Enzymes in Vinyl Carbamate Metabolism in Human Lung Microsomes
      Poh-Gek Forkert, Raymond P. Lee and Ken Reid
      Drug Metabolism and Disposition March 2001, 29 (3) 258-263;

  2. Rypka, Miroslav

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

S

  1. Sasano, Hironobu

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  2. Sausville, Edward A.

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  3. Scheff, Stephen

    1. Tissue-Specific Alterations in the 6-Hydroxylation of Chlorzoxazone Following Traumatic Brain Injury in the Rat
      Samuel M. Poloyac, Alex Perez, Stephen Scheff and Robert A. Blouin
      Drug Metabolism and Disposition March 2001, 29 (3) 296-298;

  4. Scudiero, Dominic A.

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  5. Shimada, Miki

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  6. Siest, Jean-Pascal

    1. Novel Mutations of CYP3A4 in Chinese
      Kun-Pin Hsieh, Yen-Yu Lin, Ching-Ling Cheng, Ming-Liang Lai, Min-Shung Lin, Jean-Pascal Siest and Jin-Ding Huang
      Drug Metabolism and Disposition March 2001, 29 (3) 268-273;

  7. Silva, Jose M.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  8. Srivastava, Alok

    1. Glutathione S-Transferase Activity Influences Busulfan Pharmacokinetics in Patients with Beta Thalassemia Major Undergoing Bone Marrow Transplantation
      Balasubramanian Poonkuzhali, Mammen Chandy, Alok Srivastava, David Dennison and Rajagopal Krishnamoorthy
      Drug Metabolism and Disposition March 2001, 29 (3) 264-267;

  9. Stevens, Jan F.

    1. In Vitro Biotransformation of Xanthohumol, a Flavonoid from Hops (Humulus lupulus), by Rat Liver Microsomes
      Meltem Yilmazer, Jan F. Stevens, Max L. Deinzer and Donald R. Buhler
      Drug Metabolism and Disposition March 2001, 29 (3) 223-231;

  10. Stevens, Jeffrey C.

    1. Characterization of 2-[[4-[[2-(1H-Tetrazol-5-ylmethyl)phenyl]methoxy]phenoxy]methyl] Quinoline N-Glucuronidation by in Vitro and in Vivo Approaches
      Jeffrey C. Stevens, Jessica L. Fayer and Kenneth C. Cassidy
      Drug Metabolism and Disposition March 2001, 29 (3) 289-295;

  11. Sugiyama, Yuichi

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  12. Sung, Sang Hyun

    1. Lack of Cytochrome P450 2E1 (CYP2E1) Induction in the Rat Liver by Starvation without Coprophagy
      Hye Chin Chung, Sang Hyun Sung, Jin Soo Kim, Young Choong Kim and Sang Geon Kim
      Drug Metabolism and Disposition March 2001, 29 (3) 213-216;

T

  1. Taavitsainen, Päivi

    1. In Vitro Inhibition of Cytochrome P450 Enzymes in Human Liver Microsomes by a Potent CYP2A6 inhibitor, trans-2-Phenylcyclopropylamine (Tranylcypromine), and Its Nonamine Analog, Cyclopropylbenzene
      Päivi Taavitsainen, Risto Juvonen and Olavi Pelkonen
      Drug Metabolism and Disposition March 2001, 29 (3) 217-222;

  2. Takasaki, Wataru

    1. A Comparison of the Effects of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors on the CYP3A4-Dependent Oxidation of Mexazolam in Vitro
      Michi Ishigami, Tomoyo Honda, Wataru Takasaki, Toshihiko Ikeda, Toru Komai, Kiyomi Ito and Yuichi Sugiyama
      Drug Metabolism and Disposition March 2001, 29 (3) 282-288;

  3. Tan, Eugene

    1. Sulfation is Rate Limiting in the Futile Cycling Between Estrone and Estrone Sulfate in Enriched Periportal and Perivenous Rat Hepatocytes
      Eugene Tan and K. Sandy Pang
      Drug Metabolism and Disposition March 2001, 29 (3) 335-346;

  4. Trimble, Laird A.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

V

  1. Veselý, Jaroslav

    1. In Vivo Metabolism of 2,6,9-Trisubstituted Purine-Derived Cyclin-Dependent Kinase Inhibitor Bohemine in Mice: Glucosidation as the Principal Metabolic Route
      Zdeněk Chmela, Jaroslav Veselý, Karel Lemr, Miroslav Rypka, Jan Hanuš, Libor Havlı́ček, Vladimı́r Kryštof, Lucie Michnová, Květoslava Fuksová and Jiřı́ Lukeš
      Drug Metabolism and Disposition March 2001, 29 (3) 326-334;

W

  1. Waechter, Felix

    1. Induction of CYP2C Genes in Human Hepatocytes in Primary Culture
      Sabine Gerbal-Chaloin, Jean-Marc Pascussi, Lydiane Pichard-Garcia, Martine Daujat, Felix Waechter, Jean-Michel Fabre, Nicolas Carrère and Patrick Maurel
      Drug Metabolism and Disposition March 2001, 29 (3) 242-251;

  2. Warrellow, Graham J.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  3. Waxman, David J.

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

  4. Weigl, Paul

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  5. Wiltshire, Hugh

    1. Elevated Alpha-1-Acid Glycoprotein Reduces the Volume of Distribution and Systemic Clearance of Saquinavir
      John W. Holladay, Michael J. Dewey, Bozena B. Michniak, Hugh Wiltshire, Daniel L. Halberg, Paul Weigl, Zhenmin Liang, Kathryn Halifax, W. Edward Lindup and David J. Back
      Drug Metabolism and Disposition March 2001, 29 (3) 299-303;

  6. Wolf, C. Roland

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

  7. Wong, Bradley K.

    1. PSA-Specific and Non-PSA-Specific Conversion of a PSA-Targeted Peptide Conjugate of Doxorubicin to Its Active Metabolites
      Bradley K. Wong, Deborah DeFeo-Jones, Raymond E. Jones, Victor M. Garsky, Dong-Mei Feng, Allen Oliff, Masato Chiba, Joan D. Ellis and Jiunn H. Lin
      Drug Metabolism and Disposition March 2001, 29 (3) 313-318;

Y

  1. Yamazoe, Yasushi

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  2. Yergey, James A.

    1. Investigation of the in Vitro Metabolism Profile of a Phosphodiesterase-IV Inhibitor, CDP-840: Leading to Structural Optimization
      Chun Li, Nathalie Chauret, Laird A. Trimble, Deborah A. Nicoll-Griffith, Jose M. Silva, Dwight MacDonald, Helene Perrier, James A. Yergey, Ted Parton, Rakki P. Alexander and Graham J. Warrellow
      Drug Metabolism and Disposition March 2001, 29 (3) 232-241;

  3. Yilmazer, Meltem

    1. In Vitro Biotransformation of Xanthohumol, a Flavonoid from Hops (Humulus lupulus), by Rat Liver Microsomes
      Meltem Yilmazer, Jan F. Stevens, Max L. Deinzer and Donald R. Buhler
      Drug Metabolism and Disposition March 2001, 29 (3) 223-231;

  4. Yoshinari, Kouichi

    1. Enzymatic Characterization and Interspecies Difference of Phenol Sulfotransferases, ST1A Forms
      Wataru Honma, Yoshiteru Kamiyama, Kouichi Yoshinari, Hironobu Sasano, Miki Shimada, Kiyoshi Nagata and Yasushi Yamazoe
      Drug Metabolism and Disposition March 2001, 29 (3) 274-281;

  5. Yu, Li J.

    1. P450 Enzyme Expression Patterns in the NCI Human Tumor Cell Line Panel
      Li J. Yu, Jocelyn Matias, Dominic A. Scudiero, Karen M. Hite, Anne Monks, Edward A. Sausville and David J. Waxman
      Drug Metabolism and Disposition March 2001, 29 (3) 304-312;

Z

  1. Zangar, Richard C.

    1. Differential Induction of Rat Hepatic Cytochromes P450 3A1, 3A2, 2B1, 2B2, and 2E1 in Response to Pyridine Treatment
      Hyesook Kim, David A. Putt, Richard C. Zangar, C. Roland Wolf, F. Peter Guengerich, Robert J. Edwards, Paul F. Hollenberg and Raymond F. Novak
      Drug Metabolism and Disposition March 2001, 29 (3) 353-360;

  2. Zhang, Qing-Yu

    1. Metabolic Characterization of the Major Human Small Intestinal Cytochrome P450s
      R. Scott Obach, Qing-Yu Zhang, Deborah Dunbar and Laurence S. Kaminsky
      Drug Metabolism and Disposition March 2001, 29 (3) 347-352;
Back to top

In this issue